Christopher Murray
Chief Tech/Sci/R&D Officer presso BLUEPRINT MEDICINES CORPORATION
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Christopher K.
Murray is currently the Chief Technical Operations & Quality Officer at Blueprint Medicines Corp.
Prior to this, he worked at ARIAD Pharmaceuticals, Inc. for 13 years, where he held the position of Vice President-Technical Operations from 2013 to 2017.
Murray received his undergraduate degree from Hope College in 1984 and his graduate degree from The University of Chicago in 1990.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 07/03/2024 | 33 853 ( 0.06% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Christopher Murray
| Società | Posizione | Inizio |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Tech/Sci/R&D Officer | 10/10/2017 |
Precedenti posizioni note di Christopher Murray
| Società | Posizione | Fine |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2017 |
Formazione di Christopher Murray
| Hope College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Christopher Murray
